• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

右美沙芬可减少氧化应激并抑制尿毒症性动脉钙化。

Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification.

机构信息

Division of Cardiology, Kaohsiung Veterans General Hospital, Kaohsiung 813779, Taiwan.

Institutes of Clinical Medicine, National Yang Ming Chiao Tung University, Hsinchu City 30010, Taiwan.

出版信息

Int J Mol Sci. 2021 Nov 13;22(22):12277. doi: 10.3390/ijms222212277.

DOI:10.3390/ijms222212277
PMID:34830159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8623041/
Abstract

Medial vascular calcification has emerged as a key factor contributing to cardiovascular mortality in patients with chronic kidney disease (CKD). Vascular smooth muscle cells (VSMCs) with osteogenic transdifferentiation play a role in vascular calcification. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitors reduce reactive oxygen species (ROS) production and calcified-medium-induced calcification of VSMCs. This study investigates the effects of dextromethorphan (DXM), an NADPH oxidase inhibitor, on vascular calcification. We used in vitro and in vivo studies to evaluate the effect of DXM on artery changes in the presence of hyperphosphatemia. The anti-vascular calcification effect of DXM was tested in adenine-fed Wistar rats. High-phosphate medium induced ROS production and calcification of VSMCs. DXM significantly attenuated the increase in ROS production, the decrease in ATP, and mitochondria membrane potential during the calcified-medium-induced VSMC calcification process ( < 0.05). The protective effect of DXM in calcified-medium-induced VSMC calcification was not further increased by NADPH oxidase inhibitors, indicating that NADPH oxidase mediates the effect of DXM. Furthermore, DXM decreased aortic calcification in Wistar rats with CKD. Our results suggest that treatment with DXM can attenuate vascular oxidative stress and ameliorate vascular calcification.

摘要

血管中层钙化已成为慢性肾脏病(CKD)患者心血管死亡率的一个关键因素。具有成骨转化的血管平滑肌细胞(VSMCs)在血管钙化中起作用。烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶抑制剂可减少活性氧(ROS)的产生和钙化介质诱导的 VSMC 钙化。本研究探讨了 NADPH 氧化酶抑制剂右美沙芬(DXM)对血管钙化的影响。我们使用体外和体内研究来评估 DXM 在高磷血症存在下对动脉变化的影响。在腺嘌呤喂养的 Wistar 大鼠中测试了 DXM 的抗血管钙化作用。高磷培养基诱导 VSMC 产生 ROS 和钙化。DXM 显著减弱了钙化介质诱导的 VSMC 钙化过程中 ROS 产生的增加、ATP 的减少和线粒体膜电位的降低(<0.05)。NADPH 氧化酶抑制剂不能进一步增加 DXM 在钙化介质诱导的 VSMC 钙化中的保护作用,表明 NADPH 氧化酶介导了 DXM 的作用。此外,DXM 降低了 CKD Wistar 大鼠的主动脉钙化。我们的结果表明,DXM 的治疗可以减轻血管氧化应激并改善血管钙化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02b3/8623041/ada054d6af50/ijms-22-12277-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02b3/8623041/a74fbebac813/ijms-22-12277-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02b3/8623041/76f6286cb1e1/ijms-22-12277-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02b3/8623041/16cd62a376ad/ijms-22-12277-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02b3/8623041/672a9520de66/ijms-22-12277-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02b3/8623041/d3a3730513f2/ijms-22-12277-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02b3/8623041/6f95c323fc3a/ijms-22-12277-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02b3/8623041/ada054d6af50/ijms-22-12277-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02b3/8623041/a74fbebac813/ijms-22-12277-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02b3/8623041/76f6286cb1e1/ijms-22-12277-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02b3/8623041/16cd62a376ad/ijms-22-12277-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02b3/8623041/672a9520de66/ijms-22-12277-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02b3/8623041/d3a3730513f2/ijms-22-12277-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02b3/8623041/6f95c323fc3a/ijms-22-12277-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02b3/8623041/ada054d6af50/ijms-22-12277-g007.jpg

相似文献

1
Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification.右美沙芬可减少氧化应激并抑制尿毒症性动脉钙化。
Int J Mol Sci. 2021 Nov 13;22(22):12277. doi: 10.3390/ijms222212277.
2
Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.在一种改良的、基于腺嘌呤的尿毒症大鼠模型中,磷酸盐结合剂可预防磷酸盐诱导的血管平滑肌细胞衰老和血管钙化。
Calcif Tissue Int. 2015 Apr;96(4):347-58. doi: 10.1007/s00223-014-9929-5. Epub 2014 Dec 16.
3
The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease.抗氧化剂替米泊芬可改善尿毒症大鼠的动脉中层钙化:氧化应激在慢性肾脏病血管钙化发病机制中的重要作用。
J Bone Miner Res. 2012 Feb;27(2):474-85. doi: 10.1002/jbmr.539.
4
Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.c1q/肿瘤坏死因子相关蛋白-3 的过表达促进体内外磷酸盐诱导的血管平滑肌细胞钙化。
Arterioscler Thromb Vasc Biol. 2014 May;34(5):1002-10. doi: 10.1161/ATVBAHA.114.303301. Epub 2014 Feb 27.
5
Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice.右美沙芬可减轻小鼠的氧化应激反应,并抑制动脉粥样硬化和新生内膜形成。
Cardiovasc Res. 2009 Apr 1;82(1):161-9. doi: 10.1093/cvr/cvp043. Epub 2009 Feb 3.
6
Oxidative stress by Ca overload is critical for phosphate-induced vascular calcification.钙超载导致的氧化应激对于磷酸盐诱导的血管钙化至关重要。
Am J Physiol Heart Circ Physiol. 2020 Dec 1;319(6):H1302-H1312. doi: 10.1152/ajpheart.00305.2020. Epub 2020 Oct 23.
7
Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification.炎症细胞因子和活性氧作为慢性肾脏病相关血管钙化的介质
Am J Hypertens. 2015 Jun;28(6):746-55. doi: 10.1093/ajh/hpu225. Epub 2014 Nov 27.
8
The Crosstalk between Calcium Ions and Aldosterone Contributes to Inflammation, Apoptosis, and Calcification of VSMC via the AIF-1/NF-B Pathway in Uremia.钙离子与醛固酮之间的相互作用通过尿毒症中AIF-1/NF-κB途径导致血管平滑肌细胞炎症、凋亡和钙化。
Oxid Med Cell Longev. 2020 Dec 4;2020:3431597. doi: 10.1155/2020/3431597. eCollection 2020.
9
Sirt7 protects against vascular calcification via modulation of reactive oxygen species and senescence of vascular smooth muscle cells.Sirt7 通过调节活性氧和血管平滑肌细胞衰老来防止血管钙化。
Free Radic Biol Med. 2024 Oct;223:30-41. doi: 10.1016/j.freeradbiomed.2024.07.021. Epub 2024 Jul 23.
10
Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells.二肽基肽酶-4抑制剂吉格列汀在实验性慢性肾病和血管平滑肌细胞中可预防血管钙化。
PLoS One. 2017 Jul 7;12(7):e0180393. doi: 10.1371/journal.pone.0180393. eCollection 2017.

引用本文的文献

1
Hyperphosphataemia and NADPH Oxidase Regulation in Pathophysiological Processes: Implications for Oxidative Stress and Disease Progression.病理生理过程中的高磷血症与NADPH氧化酶调节:对氧化应激和疾病进展的影响
Antioxidants (Basel). 2025 Apr 12;14(4):461. doi: 10.3390/antiox14040461.
2
Anti-epileptic and Neuroprotective Effects of Ultra-low Dose NADPH Oxidase Inhibitor Dextromethorphan on Kainic Acid-induced Chronic Temporal Lobe Epilepsy in Rats.超低剂量烟酰胺腺嘌呤二核苷酸磷酸氧化酶抑制剂右美沙芬对红藻氨酸诱导的大鼠慢性颞叶癫痫的抗癫痫和神经保护作用。
Neurosci Bull. 2024 May;40(5):577-593. doi: 10.1007/s12264-023-01140-8. Epub 2023 Nov 16.
3

本文引用的文献

1
Regulation of Vascular Calcification by Reactive Oxygen Species.活性氧对血管钙化的调节作用
Antioxidants (Basel). 2020 Oct 8;9(10):963. doi: 10.3390/antiox9100963.
2
Excessive Fructose Intake Impairs Baroreflex Sensitivity and Led to Elevated Blood Pressure in Rats.过量果糖摄入损害大鼠压力感受性反射敏感性并导致血压升高。
Nutrients. 2019 Oct 25;11(11):2581. doi: 10.3390/nu11112581.
3
Salusin-β Promotes Vascular Calcification Nicotinamide Adenine Dinucleotide Phosphate/Reactive Oxygen Species-Mediated Klotho Downregulation.
Protection of pancreatic islets from oxidative cell death by a peripherally-active morphinan with increased drug safety.
通过外周作用的阿片样物质增加药物安全性来保护胰岛细胞免于氧化细胞死亡。
Mol Metab. 2023 Sep;75:101775. doi: 10.1016/j.molmet.2023.101775. Epub 2023 Jul 12.
4
Oxidative Stress and Mitochondrial Dysfunction in Chronic Kidney Disease.慢性肾脏病中的氧化应激与线粒体功能障碍。
Cells. 2022 Dec 25;12(1):88. doi: 10.3390/cells12010088.
5
Inhibition of the Semaphorin 4D-Plexin-B1 axis prevents calcification in vascular smooth muscle cells.抑制信号素 4D-神经纤毛蛋白 1 轴可防止血管平滑肌细胞钙化。
BMB Rep. 2023 Mar;56(2):160-165. doi: 10.5483/BMBRep.2022-0165.
6
Phenotypic plasticity of vascular smooth muscle cells in vascular calcification: Role of mitochondria.血管钙化中血管平滑肌细胞的表型可塑性:线粒体的作用
Front Cardiovasc Med. 2022 Oct 12;9:972836. doi: 10.3389/fcvm.2022.972836. eCollection 2022.
沙利森-β促进血管钙化 烟酰胺腺嘌呤二核苷酸磷酸/活性氧簇介导 klotho 下调。
Antioxid Redox Signal. 2019 Dec 20;31(18):1352-1370. doi: 10.1089/ars.2019.7723.
4
Phenotypic Modulation of Cultured Primary Human Aortic Vascular Smooth Muscle Cells by Uremic Serum.尿毒症血清对培养的原代人主动脉血管平滑肌细胞的表型调节
Front Physiol. 2018 Feb 12;9:89. doi: 10.3389/fphys.2018.00089. eCollection 2018.
5
Tail-Cuff Technique and Its Influence on Central Blood Pressure in the Mouse.尾套法及其对小鼠中心血压的影响。
J Am Heart Assoc. 2017 Jun 27;6(6):e005204. doi: 10.1161/JAHA.116.005204.
6
Apocynin attenuates angiotensin II-induced vascular smooth muscle cells osteogenic switching via suppressing extracellular signal-regulated kinase 1/2.白杨素通过抑制细胞外信号调节激酶1/2减轻血管紧张素II诱导的血管平滑肌细胞成骨转化。
Oncotarget. 2016 Dec 13;7(50):83588-83600. doi: 10.18632/oncotarget.13193.
7
The molecular biology and pathophysiology of vascular calcification.血管钙化的分子生物学和病理生理学。
Postgrad Med. 2014 Mar;126(2):54-64. doi: 10.3810/pgm.2014.03.2740.
8
Inflammatory, metabolic, and genetic mechanisms of vascular calcification.血管钙化的炎症、代谢和遗传机制。
Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):715-23. doi: 10.1161/ATVBAHA.113.302070.
9
Low-dose dextromethorphan, a NADPH oxidase inhibitor, reduces blood pressure and enhances vascular protection in experimental hypertension.低剂量右美沙芬,一种 NADPH 氧化酶抑制剂,可降低血压并增强实验性高血压中的血管保护作用。
PLoS One. 2012;7(9):e46067. doi: 10.1371/journal.pone.0046067. Epub 2012 Sep 25.
10
High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.大剂量右美沙芬,一种 NMDA 拮抗剂,产生的效果类似于经典的致幻剂。
Psychopharmacology (Berl). 2012 Sep;223(1):1-15. doi: 10.1007/s00213-012-2680-6. Epub 2012 Apr 13.